Capricor Therapeutics, Inc. earnings per share and revenue

CAPR earnings per share for the last quarter are -0.02 USD whereas the estimation was -0.09 USD which accounts for 77.78% surprise. Company revenue for the same period amounts to 12.09 M USD despite the estimated figure of 10.60 M USD. Estimated earnings per share for the next quarter are -0.11 USD, and revenue is expected to reach 9.70 M USD. Also watch annual changes over time to get a bigger picture of CAPR earnings per share and revenue dynamics.